<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
                      "http://www.w3.org/TR/html4/strict.dtd">
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=US-ASCII">
<meta name="generator" content="hypermail 2.1.5, see http://www.hypermail.org/">
<title>Extropians: RE: Performance enhancement with donepezil</title>
<meta name="Author" content="Rafal Smigrodzki (rms2g@virginia.edu)">
<meta name="Subject" content="RE: Performance enhancement with donepezil">
<meta name="Date" content="2003-01-28">
<style type="text/css">
body {color: black; background: #ffffff}
h1.center {text-align: center}
div.center {text-align: center}
</style>
</head>
<body>
<h1>RE: Performance enhancement with donepezil</h1>
<!-- received="Tue Jan 28 06:54:36 2003" -->
<!-- isoreceived="20030128135436" -->
<!-- sent="Tue, 28 Jan 2003 09:03:24 -0500" -->
<!-- isosent="20030128140324" -->
<!-- name="Rafal Smigrodzki" -->
<!-- email="rms2g@virginia.edu" -->
<!-- subject="RE: Performance enhancement with donepezil" -->
<!-- id="BMEDJIBJGLNDOOANGIDLMEEOCJAA.rms2g@virginia.edu" -->
<!-- charset="US-ASCII" -->
<!-- inreplyto="3E367836.7040200@ramonsky.com" -->
<!-- expires="-1" -->
<p>
<strong>From:</strong> Rafal Smigrodzki (<a href="mailto:rms2g@virginia.edu?Subject=RE:%20Performance%20enhancement%20with%20donepezil"><em>rms2g@virginia.edu</em></a>)<br>
<strong>Date:</strong> Tue Jan 28 2003 - 07:03:24 MST
</p>
<!-- next="start" -->
<ul>
<li><strong>Next message:</strong> <a href="1575.html">Enrique: "(no subject)"</a>
<li><strong>Previous message:</strong> <a href="1573.html">Spudboy100@aol.com: "Re: Nanotech Super-soldier articles etc."</a>
<li><strong>In reply to:</strong> <a href="1572.html">Alex Ramonsky: "Re: Performance enhancement with donepezil"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="1640.html">Alex Ramonsky: "Re: Performance enhancement with donepezil"</a>
<li><strong>Reply:</strong> <a href="1640.html">Alex Ramonsky: "Re: Performance enhancement with donepezil"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#1574">[ date ]</a>
<a href="index.html#1574">[ thread ]</a>
<a href="subject.html#1574">[ subject ]</a>
<a href="author.html#1574">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<hr>
<!-- body="start" -->
<p>
Alex Ramonsky wrote:
<br>
<em>&gt; Rafal Smigrodzki wrote:
</em><br>
<em>&gt;
</em><br>
<em>&gt;&gt; [snip]
</em><br>
<em>&gt;&gt; This said, I would not recommend sustained use of AChE inhibitors in
</em><br>
<em>&gt;&gt; healthy persons, except on a temporary basis. Their safety has not
</em><br>
<em>&gt;&gt; been tested in long-term studies on healthy volunteers. If there are
</em><br>
<em>&gt;&gt; adventurous spirits willing to expose their brains to some (probably
</em><br>
<em>&gt;&gt; small) risk for the sake of clearer thinking, I wish we could track
</em><br>
<em>&gt;&gt; their progress over a few years.
</em><br>
<em>&gt;&gt;
</em><br>
<em>&gt;&gt; Rafal
</em><br>
<em>&gt;&gt;
</em><br>
<em>&gt;&gt;
</em><br>
<em>&gt;&gt;
</em><br>
<em>&gt; ...you _pay_ for it, dude, I'll take 'em.   : )
</em><br>
<em>&gt; And you can have as much progress-tracking as you like. Sounds like a
</em><br>
<em>&gt; fair deal to me? ...Get a commitee to fund it, I would.
</em><br>
<em>&gt; Ramonsky
</em><br>
<p>### I am sure Eisai and Pfizer would be happy to give you all the pills you
<br>
could take in a controlled trial of cognitive enhancement but most likely
<br>
the FDA would fight tooth and nail to stop it.
<br>
<p>Rafal
<br>
<!-- body="end" -->
<hr>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="1575.html">Enrique: "(no subject)"</a>
<li><strong>Previous message:</strong> <a href="1573.html">Spudboy100@aol.com: "Re: Nanotech Super-soldier articles etc."</a>
<li><strong>In reply to:</strong> <a href="1572.html">Alex Ramonsky: "Re: Performance enhancement with donepezil"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="1640.html">Alex Ramonsky: "Re: Performance enhancement with donepezil"</a>
<li><strong>Reply:</strong> <a href="1640.html">Alex Ramonsky: "Re: Performance enhancement with donepezil"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#1574">[ date ]</a>
<a href="index.html#1574">[ thread ]</a>
<a href="subject.html#1574">[ subject ]</a>
<a href="author.html#1574">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<!-- trailer="footer" -->
<hr>
<p><small><em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2.1.5</a> 
: Sun Feb 02 2003 - 21:26:03 MST
</em></small></p>
</body>
</html>
